These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
290 related articles for article (PubMed ID: 24114809)
1. Association between the PNPLA3 (rs738409 C>G) variant and hepatocellular carcinoma: Evidence from a meta-analysis of individual participant data. Trépo E; Nahon P; Bontempi G; Valenti L; Falleti E; Nischalke HD; Hamza S; Corradini SG; Burza MA; Guyot E; Donati B; Spengler U; Hillon P; Toniutto P; Henrion J; Franchimont D; Devière J; Mathurin P; Moreno C; Romeo S; Deltenre P Hepatology; 2014 Jun; 59(6):2170-7. PubMed ID: 24114809 [TBL] [Abstract][Full Text] [Related]
2. Carriage of the PNPLA3 rs738409 C >G polymorphism confers an increased risk of non-alcoholic fatty liver disease associated hepatocellular carcinoma. Liu YL; Patman GL; Leathart JB; Piguet AC; Burt AD; Dufour JF; Day CP; Daly AK; Reeves HL; Anstee QM J Hepatol; 2014 Jul; 61(1):75-81. PubMed ID: 24607626 [TBL] [Abstract][Full Text] [Related]
3. The PNPLA3 rs738409 148M/M genotype is a risk factor for liver cancer in alcoholic cirrhosis but shows no or weak association in hepatitis C cirrhosis. Nischalke HD; Berger C; Luda C; Berg T; Müller T; Grünhage F; Lammert F; Coenen M; Krämer B; Körner C; Vidovic N; Oldenburg J; Nattermann J; Sauerbruch T; Spengler U PLoS One; 2011; 6(11):e27087. PubMed ID: 22087248 [TBL] [Abstract][Full Text] [Related]
4. Association between PNPLA3 (rs738409 C>G) variant and hepatocellular carcinoma in Asian chronic hepatitis C patients: A longitudinal study. Yen YH; Tsai MC; Wu CK; Chang KC; Hung CH; Chiu KW; Lu SN; Wang JH; Chen CH; Kee KM; Kuo YH; Tseng PL; Lin MT; Huang CM; Lin JT; Hu TH J Formos Med Assoc; 2018 Sep; 117(9):833-840. PubMed ID: 29089161 [TBL] [Abstract][Full Text] [Related]
5. PNPLA3 rs738409, hepatocellular carcinoma occurrence and risk model prediction in patients with cirrhosis. Guyot E; Sutton A; Rufat P; Laguillier C; Mansouri A; Moreau R; Ganne-Carrié N; Beaugrand M; Charnaux N; Trinchet JC; Nahon P J Hepatol; 2013 Feb; 58(2):312-8. PubMed ID: 23069476 [TBL] [Abstract][Full Text] [Related]
6. Association between rs738409 polymorphism in patatin-like phospholipase domain-containing protein 3 (PNPLA3) gene and hepatocellular carcinoma susceptibility: Evidence from case-control studies. Li JF; Zheng EQ; Xie M Gene; 2019 Feb; 685():143-148. PubMed ID: 30403964 [TBL] [Abstract][Full Text] [Related]
7. PNPLA3 rs738409C/G polymorphism in cirrhosis: relationship with the aetiology of liver disease and hepatocellular carcinoma occurrence. Falleti E; Fabris C; Cmet S; Cussigh A; Bitetto D; Fontanini E; Fornasiere E; Bignulin S; Fumolo E; Bignulin E; Pirisi M; Toniutto P Liver Int; 2011 Sep; 31(8):1137-43. PubMed ID: 21745286 [TBL] [Abstract][Full Text] [Related]
8. PNPLA3 rs738409 is not associated with the risk of hepatocellular carcinoma and persistent infection of hepatitis B virus (HBV) in HBV-related subjects: A case-control study and meta-analysis on Asians. Wang P; Wu C; Li Y; Gong Y; Shen N Gene; 2020 Jun; 742():144585. PubMed ID: 32173542 [TBL] [Abstract][Full Text] [Related]
9. PNPLA3 Gene Polymorphism Is Associated With Predisposition to and Severity of Alcoholic Liver Disease. Salameh H; Raff E; Erwin A; Seth D; Nischalke HD; Falleti E; Burza MA; Leathert J; Romeo S; Molinaro A; Corradini SG; Toniutto P; Spengler U; Daly A; Day CP; Kuo YF; Singal AK Am J Gastroenterol; 2015 Jun; 110(6):846-56. PubMed ID: 25964223 [TBL] [Abstract][Full Text] [Related]
10. [Effects of PNPLA3, TM6SF2 gene polymorphisms and its interactions with smoking and alcohol drinking on hepatitis B virus-associated hepatocellular carcinoma]. Wang LQ; Guo WH; Guo ZW; Qin P; Zhang R; Zhu XM; Liu DW Zhonghua Liu Xing Bing Xue Za Zhi; 2018 Dec; 39(12):1611-1616. PubMed ID: 30572387 [No Abstract] [Full Text] [Related]
11. PNPLA3 and TM6SF2 variants as risk factors of hepatocellular carcinoma across various etiologies and severity of underlying liver diseases. Yang J; Trépo E; Nahon P; Cao Q; Moreno C; Letouzé E; Imbeaud S; Gustot T; Deviere J; Debette S; Amouyel P; Bioulac-Sage P; Calderaro J; Ganne-Carrié N; Laurent A; Blanc JF; Guyot E; Sutton A; Ziol M; Zucman-Rossi J; Nault JC Int J Cancer; 2019 Feb; 144(3):533-544. PubMed ID: 30289982 [TBL] [Abstract][Full Text] [Related]
12. Genetic variants in PNPLA3 and TM6SF2 predispose to the development of hepatocellular carcinoma in individuals with alcohol-related cirrhosis. Stickel F; Buch S; Nischalke HD; Weiss KH; Gotthardt D; Fischer J; Rosendahl J; Marot A; Elamly M; Casper M; Lammert F; McQuillin A; Zopf S; Spengler U; Marhenke S; Kirstein MM; Vogel A; Eyer F; von Felden J; Wege H; Buch T; Schafmayer C; Braun F; Deltenre P; Berg T; Morgan MY; Hampe J Am J Gastroenterol; 2018 Oct; 113(10):1475-1483. PubMed ID: 29535416 [TBL] [Abstract][Full Text] [Related]
13. Impact of patatin-like phospholipase-3 (rs738409 C>G) polymorphism on fibrosis progression and steatosis in chronic hepatitis C. Trépo E; Pradat P; Potthoff A; Momozawa Y; Quertinmont E; Gustot T; Lemmers A; Berthillon P; Amininejad L; Chevallier M; Schlué J; Kreipe H; Devière J; Manns M; Trépo C; Sninsky J; Wedemeyer H; Franchimont D; Moreno C Hepatology; 2011 Jul; 54(1):60-9. PubMed ID: 21488075 [TBL] [Abstract][Full Text] [Related]
14. PNPLA3 rs738409 and TM6SF2 rs58542926 variants increase the risk of hepatocellular carcinoma in alcoholic cirrhosis. Falleti E; Cussigh A; Cmet S; Fabris C; Toniutto P Dig Liver Dis; 2016 Jan; 48(1):69-75. PubMed ID: 26493626 [TBL] [Abstract][Full Text] [Related]
15. PNPLA3 risk allele is associated with risk of hepatocellular carcinoma but not decompensation in compensated cirrhosis. Urias E; Tedesco NR; Burkholder DA; Moran IJ; Miller MJ; Jasty VSJ; Patil S; Zoellner S; Wijarnpreecha K; Chen VL Hepatol Commun; 2024 Jun; 8(6):. PubMed ID: 38780253 [TBL] [Abstract][Full Text] [Related]
16. A Variant in PNPLA3 Associated With Fibrosis Progression but not Hepatocellular Carcinoma in Patients With Hepatitis C Virus Infection. Ali M; Yopp A; Gopal P; Beg MS; Zhu H; Lee W; Singal AG Clin Gastroenterol Hepatol; 2016 Feb; 14(2):295-300. PubMed ID: 26305067 [TBL] [Abstract][Full Text] [Related]
17. Patatin-like phospholipase domain-containing 3 I148M polymorphism, steatosis, and liver damage in chronic hepatitis C. Valenti L; Rumi M; Galmozzi E; Aghemo A; Del Menico B; De Nicola S; Dongiovanni P; Maggioni M; Fracanzani AL; Rametta R; Colombo M; Fargion S Hepatology; 2011 Mar; 53(3):791-9. PubMed ID: 21319195 [TBL] [Abstract][Full Text] [Related]
18. Association Between PNPLA3 rs738409 C>G Variant and Liver-Related Outcomes in Patients With Nonalcoholic Fatty Liver Disease. Grimaudo S; Pipitone RM; Pennisi G; Celsa C; Cammà C; Di Marco V; Barcellona MR; Boemi R; Enea M; Giannetti A; Spatola F; Marchesini G; Craxì A; Petta S Clin Gastroenterol Hepatol; 2020 Apr; 18(4):935-944.e3. PubMed ID: 31419571 [TBL] [Abstract][Full Text] [Related]
19. PNPLA3 in end-stage liver disease: alcohol consumption, hepatocellular carcinoma development, and transplantation-free survival. Friedrich K; Wannhoff A; Kattner S; Brune M; Hov JR; Weiss KH; Antoni C; Dollinger M; Neumann-Haefelin C; Seufferlein T; Schemmer P; Schirmacher P; Stremmel W; Gotthardt DN J Gastroenterol Hepatol; 2014; 29(7):1477-84. PubMed ID: 25273282 [TBL] [Abstract][Full Text] [Related]